[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100449002":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":28,"responsibleParty":46,"collaborators":48,"id":52,"slug":10,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":10,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":10,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational (questionnaire)",null,"Patients complete a questionnaire over 15-20 minutes. Patients positive for a TP53 mutation complete an additional questionnaire over 15-20 minutes within 1 month after test results.",[13],"Other: Questionnaire Administration",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Questionnaire Administration","Complete questionnaire",[9],[20],{"name":21,"affiliation":5,"role":22},"Banu Arun","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","713-792-2360","barun@mdanderson.org",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"M D Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-95.36327,29.76328,{"lat":41,"lon":40},[44,45],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[49],{"name":50,"class":51},"National Cancer Institute (NCI)","NIH","100449002",false,"NCT05126810","Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling","Evaluate Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling Based on LFSPRO-ShinyApp Data","Inclusion Criteria:\n\n* Individuals age 15 or older OR parent\u002Fguardian of a patient younger than 15 years (if age 15-17, the patient will provide assent and parent\u002Fguardian will provide consent), pregnant women will also be allowed to participate\n* English fluency\n* Receive genetic counseling specifically for TP53 genetic testing and who consent to undergo TP53 genetic testing OR individuals whose genetic testing indicates a TP53 germline mutation\n\nExclusion Criteria:\n\n* Individuals who are non-English speaking\n* Individuals having low suspicion for a TP53 germline mutation during pretest counseling and test negative for a TP53 mutation","ALL",{"count":60,"type":61},500,"ESTIMATED","OBSERVATIONAL","This study evaluates patients willingness to participate in a trial comparing standard genetic counseling versus personalized genetic counseling. Collecting information from patients may help researchers learn why patients may or may not take part in the future study that compares standard genetic counseling to personalized genetic counseling.",[65],"Li-Fraumeni Syndrome","2026-04-13",{"date":68,"type":69},"2026-04-15","ACTUAL",{"date":71,"type":69},"2022-11-03",{"date":73,"type":61},"2027-10-02",{"name":5,"class":6},1]